Anticoagulation Reversal for Life-threatening Bleeding: A Case-based Presentation for the Critical Care Team

Access Activity

Overview / Abstract:

Target Audience

This activity is designed to meet the educational needs of physicians, physician assistants, nurses, pharmacists, and other healthcare professionals.

Program Overview

Direct oral anticoagulants (DOACs) are lifesaving drugs for many patients, with transformative impact for patients with atrial fibrillation (AF) and thromboembolism, but they are not without risks. Anticoagulant adverse events have presented hurdles for both healthcare providers and patients, with bleeding complications at the forefront. Although bleeding with anticoagulants is rare, it can result in serious complications necessitating effective reversal strategies. As the treatment landscape of anticoagulant reversal evolves with new approvals, it is essential that the critical care team managing patients on anticoagulation therapy have an in-depth understanding of anticoagulation reversal agents for treatment and management of bleeding. Participants of this activity will gain understanding of DOACs, the risk of bleeding with DOACs, the differences and similarities of available novel reversal agents, and most importantly, practical strategies for implementing these agents into the critical care setting.

Learning Objectives

Upon completion of this activity, participants should be better able to:

Appraise the risk of bleeding with DOAC therapy, describe the risk factors associated with bleeding, and examine the strategies to mitigate these risks in order to improve patient and healthcare system outcomes.
Differentiate between available and emerging novel, specific anticoagulation reversal agents; assessing their differences and similarities in mechanism of action; and review the latest clinical trial data and practical administration considerations.
Evaluate the role of the critical care team in developing a protocol for implementation of novel anticoagulation reversal agents and design treatment strategies for patients with bleeding complications

Expiration

May 18, 2021

Discipline(s)

Nursing CNE, Pharmacy CPE, Physician CME

Format

Online

Credits / Hours

1.5 AMA PRA Category 1 Credit(s)™

Accreditation

ACCME

Presenters / Authors / Faculty

Faculty

Gregory Piazza, MD
Chair
Assistant Professor of Medicine
Harvard Medical School
Associate Physician
Brigham and Women's Hospital
Cardiovascular Medicine
Boston, Massachusetts

John Fanikos, MBA, RPh
Assistant Professor of Clinical Pharmacy Practice
Northeastern University
Massachusetts College of Pharmacy
Director of Pharmacy Business and Financial Services
Brigham and Women’s Hospital
Boston, Massachusetts

Jorge Antonio Gutierrez, MD
Assistant Professor of Medicine
Department of Medicine; Division of Cardiology
Duke University
Durham, North Carolina

Sponsors / Supporters / Grant Providers

Portola

Keywords / Search Terms

Relias LLC Relias LLC., FREE CME., Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map